51 related articles for article (PubMed ID: 4551948)
1. Antiviral activity of antilipidemic compounds on herpes simplex virus type 1.
Mehl JK; Witiak DT; Hamparian VV; Hughes JH
Antimicrob Agents Chemother; 1980 Aug; 18(2):269-75. PubMed ID: 6255860
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of benzodioxane, chroman and dihydrobenzofuran analogs of clofibrate in a Triton hyperlipemic rat model.
Newman HA; Heilman WP; Witiak DT
Lipids; 1973 Jul; 8(7):378-84. PubMed ID: 4724016
[No Abstract] [Full Text] [Related]
3. The increased rate of ethanol removal from blood of clofibrate-treated rats.
Hawkins RA; Nielsen RC; Veech RL
Biochem J; 1974 Apr; 140(1):117-20. PubMed ID: 4451550
[TBL] [Abstract][Full Text] [Related]
4. Alterations in cholesterol and fatty acid biosynthesis in rat liver homogenates by aryloxy acids.
Olson RJ; Trumble TE; Gamble W
Biochem J; 1974 Aug; 142(2):445-8. PubMed ID: 4441387
[TBL] [Abstract][Full Text] [Related]
5. The tritium isotope effect of sn-glycerol 3-phosphate oxidase and the effects of clofenapate and N-(2-benzoyloxyethyl)norfenfluramine on the esterification of glycerol phosphate and dihydroxyacetone phosphate by rat liver mitochondria.
Bowley M; Manning R; Brindlay DN
Biochem J; 1973 Oct; 136(2):421-7. PubMed ID: 4149445
[TBL] [Abstract][Full Text] [Related]
6. Effect of the lipid-lowering agent bezafibrate on tumour growth rate in vivo.
Mulligan HD; Tisdale MJ
Br J Cancer; 1991 Dec; 64(6):1035-8. PubMed ID: 1764364
[TBL] [Abstract][Full Text] [Related]
7. Drugs affecting the synthesis of glycerides and phospholipids in rat liver. The effects of clofibrate, halofenate, fenfluramine, amphetamine, cinchocaine, chlorpromazine, demethylimipramine, mepyramine and some of their derivatives.
Brindley DN; Bowley M
Biochem J; 1975 Jun; 148(3):461-9. PubMed ID: 1200988
[TBL] [Abstract][Full Text] [Related]
8. [Metabolic interrelationships of lipids].
Gribanov GA
Usp Sovrem Biol; 1979; 87(1):16-33. PubMed ID: 373285
[No Abstract] [Full Text] [Related]
9. A review of studies on the mode of action of clofibrate and betabenzalbutyrate.
Fallon HJ; Adams LL; Lamb RG
Lipids; 1972 Feb; 7(2):106-9. PubMed ID: 4551948
[No Abstract] [Full Text] [Related]
10. Inhibition of monoacylglycerophosphate formation by chlorophenoxyisobutyrate and -benzalbutyrate.
Lamb RG; Fallon HJ
J Biol Chem; 1972 Feb; 247(4):1281-7. PubMed ID: 5010069
[No Abstract] [Full Text] [Related]
11. Inhibition of palmitoyl CoA deacylase by chlorophenoxyisobutyrate and betabenzalbutyrate.
Lamb RG; Hill PM; Fallon HJ
J Lipid Res; 1973 Jul; 14(4):459-65. PubMed ID: 4736685
[TBL] [Abstract][Full Text] [Related]
12. The effects of butyric acid derivatives on membrane-bound and soluble hydroxymethylglutaryl coenzyme A reductase of rat liver.
Gaiti A; Nessi R; Speranza ML; Montanini I; Porcellati G
Arch Int Physiol Biochim; 1971 Aug; 79(3):555-63. PubMed ID: 4107874
[No Abstract] [Full Text] [Related]
13. Mode of action of the lipid-lowering agents, clofibrate and BM 15075, on cholesterol biosynthesis in rat liver.
Berndt J; Gaumert R; Still J
Atherosclerosis; 1978 Jun; 30(2):147-52. PubMed ID: 678316
[TBL] [Abstract][Full Text] [Related]
14. Effect of clofibrate on the handling of dietary and liver fat.
Westerfeld WW; Elwood JC; Richert DA
Biochem Pharmacol; 1972 Apr; 21(8):1117-25. PubMed ID: 5034197
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
